Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (16 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← Scotland alerts

Scotland · NHS Scotland MSAN

Tresiba (insulin degludec) FlexTouch 100units/ml solution for injection 3ml pre-filled

MSAN(2023)9 · Level 2 · issued 09 Jun 2023

Reference
MSAN(2023)9
Issued
09 Jun 2023
Priority
Level 2
Valid until
January 2024 as stated by the source
Source
Signed NHS Scotland notice (PDF) ↗

What the notice states

The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.

ProductPositionResupply
1. Tresiba® FlexTouch® (Insulin degludec) 100units/ml pens will be out of stock from August 2023Out of stock—
Registration for access to the website is available to UK healthcare professionals andAvailable—

Provenance

Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.

scot:msan:2023:9

Recorded
13 Aug 2026 22:03 UTC
Capture route
Captured first-hand by ShortageSignal's scheduled check
Read from
NHS Scotland Medicine Supply Alert Notice (PDF)
Captured at
13 Aug 2026 22:03 UTC
Content hash
a63841796eb98568d663b9d3d2132aa1e18dfa2ca7d8e0e63733f70c3953be3e
sha256 of the captured bytes — proves what was captured, not that the source was correct
Source document
https://www.publications.scot.nhs.uk/files/msan-2023-09.pdf ↗

From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.